Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07731061

Clinical Performance of Two HEMA-Free Universal Adhesive Systems

Conditions: Cervical Caries, Clinical Performance of Two Step HEMA Free Universal Adhesive

Sex: All
Ages: 18 Years – 55 Years
Healthy volunteers: No
Phase: NA
Enrollment: 50
Sponsor: Cairo University

Summary

This randomized controlled clinical trial aims to compare the clinical performance of two HEMA-free universal adhesive systems used for restoring anterior cervical carious lesions. Participants will be randomly assigned to receive restorations using either a one-bottle or a two-bottle HEMA-free universal adhesive system. The clinical performance of the restorations will be evaluated over a 12-month follow-up period using Modified USPHS criteria.

Eligibility Criteria

Inclusion Criteria: . Patients aged from 18 to 55 years. * Patients with cervical carious lesions on the labial surfaces of anterior teeth. * Lesions classified as ICDAS 3 and 4. * Patients with good general health. * Patients able and willing to attend the follow-up visits at baseline, 6 months and 12 months. Exclusion Criteria: * Patients with severe or chronic periodontal disease. * Patients with poor oral hygiene or uncontrolled plaque accumulation. * Patients with bruxism or other parafunctional habits that may affect restoration survival. * Non-vital teeth. * Fractured or cracked teeth. * Teeth with defective existing cervical restorations. * Root caries extending beyond the restorative indication of the study. * Pregnant or lactating patients. * Patients with known allergy or hypersensitivity to any component of the adhesive systems or restorative material used in the study. * Patients unable to attend the scheduled follow-up visits.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07731061). StuddyBuddy aggregates publicly available trial information.